Cranbrook Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Cranbrook Wealth Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.09M	Hold	4,440	–	–	0.22%	60
2025 Q4	$919K	Buy	4,440 +1,132	+34%	+$224K	0.18%	64
2025 Q3	$613K	Buy	3,308 +118	+4%	+$20.2K	0.12%	74
2025 Q2	$487K	Buy	3,190 +35	+1%	+$5.38K	0.1%	77
2025 Q1	$523K	Sell	3,155 -1,210	-28%	-$189K	0.12%	75
2024 Q4	$631K	Buy	4,365 +200	+5%	+$31K	0.15%	68
2024 Q3	$675K	Sell	4,165 -682	-14%	-$109K	0.15%	68
2024 Q2	$708K	Buy	4,847 +2,961	+157%	+$440K	0.17%	57
2024 Q1	$298K	Hold	1,886	–	–	0.08%	83
2023 Q4	$296K	Buy	1,886 +80	+4%	+$12.3K	0.08%	81
2023 Q3	$281K	Hold	1,806	–	–	0.08%	77
2023 Q2	$299K	Hold	1,806	–	–	0.08%	78
2023 Q1	$280K	Hold	1,806	–	–	0.08%	82
2022 Q4	$319K	Sell	1,806 -482	-21%	-$83.2K	0.09%	79
2022 Q3	$374K	Hold	2,288	–	–	0.1%	78
2022 Q2	$406K	Hold	2,288	–	–	0.1%	77
2022 Q1	$405K	Sell	2,288 -10	-0.4%	-$1.7K	0.09%	85
2021 Q4	$393K	Hold	2,298	–	–	0.08%	85
2021 Q3	$371K	Buy	2,298 +120	+6%	+$20.5K	0.08%	85
2021 Q2	$359K	Sell	2,178 -28	-1%	-$4.64K	0.08%	85
2021 Q1	$363K	Buy	2,206 +28	+1%	+$4.53K	0.09%	83
2020 Q4	$343K	Hold	2,178	–	–	0.09%	81
2020 Q3	$324K	Hold	2,178	–	–	0.09%	75
2020 Q2	$306K	Hold	2,178	–	–	0.09%	78
2020 Q1	$286K	Hold	2,178	–	–	0.1%	71
2019 Q4	$318K	Sell	2,178 -131	-6%	-$17.8K	0.09%	73
2019 Q3	$299K	Hold	2,309	–	–	0.09%	75
2019 Q2	$322K	Hold	2,309	–	–	0.09%	71
2019 Q1	$323K	Hold	2,309	–	–	0.1%	67
2018 Q4	$298K	Buy	2,309 +482	+26%	+$67.2K	0.1%	64
2018 Q3	$252K	Hold	1,827	–	–	0.09%	62
2018 Q2	$222K	Hold	1,827	–	–	0.09%	62
2018 Q1	$234K	Hold	1,827	–	–	0.09%	61
2017 Q4	$255K	Hold	1,827	–	–	0.1%	61
2017 Q3	$238K	Hold	1,827	–	–	0.1%	60
2017 Q2	$242K	Hold	1,827	–	–	0.11%	60
2017 Q1	$228K	Hold	1,827	–	–	0.11%	57
2016 Q4	$210K	Hold	1,827	–	–	0.1%	58
2016 Q3	$216K	Hold	1,827	–	–	0.11%	53
2016 Q2	$222K	Hold	1,827	–	–	0.11%	51
2016 Q1	$198K	Hold	1,827	–	–	0.1%	52
2015 Q4	$188K	Hold	1,827	–	–	0.11%	53
2015 Q3	$171K	Hold	1,827	–	–	0.1%	53
2015 Q2	$178K	Sell	1,827 -1,000	-35%	-$100K	0.1%	55
2015 Q1	$284K	Buy	2,827 +206	+8%	+$20.9K	0.17%	47
2014 Q4	$274K	Hold	2,621	–	–	0.17%	48
2014 Q3	$279K	Hold	2,621	–	–	0.19%	40
2014 Q2	$274K	Hold	2,621	–	–	0.18%	41
2014 Q1	$257K	Sell	2,621 -2,055	-44%	-$191K	0.18%	41
2013 Q4	$428K	Buy	+4,676	New	+$431K	0.29%	41

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cranbrook Wealth Management's JNJ Position: Q1 2026 in Review

Cranbrook Wealth Management held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 4,440 shares worth $1.09M. The position accounts for 0.22% of the portfolio, ranked #60.

Cranbrook Wealth Management first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Cranbrook Wealth Management held 4,440 shares of Johnson & Johnson worth $1.09M as of Q1 2026.
Cranbrook Wealth Management left its Johnson & Johnson share count unchanged in Q1 2026.
Johnson & Johnson made up 0.22% of Cranbrook Wealth Management's portfolio in Q1 2026, its #60 holding.
Cranbrook Wealth Management first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cranbrook Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.